1 |
Wedemeyer H, Di Marco V, Garcia-retortillo M, Teti E, Fraser C, Morano Amado LE, Rodriguez-tajes S, Acosta-lópez S, O’loan J, Milella M, Buti M, Guerra-veloz MF, Ramji A, Fenech M, Martins A, Borgia SM, Vanstraelen K, Mertens M, Hernández C, Ntalla I, Ramroth H, Milligan S. Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders. Viruses 2022;14:2493. [DOI: 10.3390/v14112493] [Reference Citation Analysis]
|
2 |
Rosati S, Wong A, Marco VD, Pérez-hernandez P, Macedo G, Brixko C, Ranieri R, Campanale F, Basciá A, Fernández-rodríguez C, Lédinghen VD, Maida I, Teti E, Mangia A, Vanstraelen K, Hernández C, Mertens M, Ntalla I, Ramroth H, Jiménez E. Real-world effectiveness of sofosbuvir/velpatasvir for the treatment of hepatitis C virus in prison settings. Future Virology 2022;17:419-28. [DOI: 10.2217/fvl-2022-0016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|